6-32062138-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.7168+19C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00521 in 1,604,262 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0048 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 99 hom. )

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.181

Publications

1 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-32062138-G-T is Benign according to our data. Variant chr6-32062138-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00484 (737/152310) while in subpopulation SAS AF = 0.0135 (65/4830). AF 95% confidence interval is 0.0108. There are 4 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.7168+19C>A intron_variant Intron 20 of 43 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.7909+19C>A intron_variant Intron 21 of 44 NP_001415264.1
TNXBNM_019105.8 linkc.7168+19C>A intron_variant Intron 20 of 43 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.7168+19C>A intron_variant Intron 20 of 43 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.7909+19C>A intron_variant Intron 21 of 44 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.7168+19C>A intron_variant Intron 20 of 43 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00485
AC:
738
AN:
152192
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00654
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0134
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00484
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00646
AC:
1545
AN:
239338
AF XY:
0.00717
show subpopulations
Gnomad AFR exome
AF:
0.000718
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.0284
Gnomad EAS exome
AF:
0.0114
Gnomad FIN exome
AF:
0.000521
Gnomad NFE exome
AF:
0.00444
Gnomad OTH exome
AF:
0.0109
GnomAD4 exome
AF:
0.00525
AC:
7619
AN:
1451952
Hom.:
99
Cov.:
32
AF XY:
0.00564
AC XY:
4068
AN XY:
720708
show subpopulations
African (AFR)
AF:
0.00207
AC:
69
AN:
33262
American (AMR)
AF:
0.00473
AC:
209
AN:
44226
Ashkenazi Jewish (ASJ)
AF:
0.0296
AC:
764
AN:
25808
East Asian (EAS)
AF:
0.0398
AC:
1569
AN:
39460
South Asian (SAS)
AF:
0.0119
AC:
1017
AN:
85406
European-Finnish (FIN)
AF:
0.000690
AC:
36
AN:
52178
Middle Eastern (MID)
AF:
0.0228
AC:
131
AN:
5734
European-Non Finnish (NFE)
AF:
0.00310
AC:
3432
AN:
1105878
Other (OTH)
AF:
0.00653
AC:
392
AN:
60000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
446
893
1339
1786
2232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00484
AC:
737
AN:
152310
Hom.:
4
Cov.:
32
AF XY:
0.00533
AC XY:
397
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41574
American (AMR)
AF:
0.00654
AC:
100
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0251
AC:
87
AN:
3468
East Asian (EAS)
AF:
0.0133
AC:
69
AN:
5182
South Asian (SAS)
AF:
0.0135
AC:
65
AN:
4830
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10616
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00484
AC:
329
AN:
68016
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00946
Hom.:
3
Bravo
AF:
0.00521
Asia WGS
AF:
0.0110
AC:
39
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
8.6
DANN
Benign
0.74
PhyloP100
-0.18
PromoterAI
0.012
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11752495; hg19: chr6-32029915; COSMIC: COSV64490498; COSMIC: COSV64490498; API